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Adherence to transfusion strategies in a randomized
controlled trial: experiences from the TITRe2 trial
The Transfusion Indication Threshold Reduction (TITRe2)
trial compared the effect of restrictive and liberal transfusion
thresholds after cardiac surgery on post-operative morbidity.
Seventeen UK centres randomized 2003 patients. Methods
and primary results have been reported (Brierley et al, 2014;
Murphy et al, 2015; Pike et al, 2015). The trial was prag-
matic: clinicians could deviate from the allocated protocol
but had to document why. Nevertheless, to be successful, the
trial had to create groups with substantially different haemo-
globin concentrations and red cell transfusion rates. Non-
adherence attenuates these differences and reduces statistical
power. Hence, monitoring adherence to the transfusion pro-
tocols was a key requirement.
Here, we report our methods for identifying, classifying
and describing non-adherence and analyses to identify cir-
cumstances in which different types of non-adherence
occurred. We also describe initiatives to minimize non-
adherence.
We identified two types of non-adherence (not pre-speci-
fied in the protocol): ‘extra’ transfusions given when not
indicated by the protocol and ‘withheld’ transfusions not
given when indicated. Non-adherence was categorized as sev-
ere when it changed the overall transfusion rate and as mild
or moderate when it only affected red cell units transfused
(Pike et al, 2015). Figure S1 shows examples of non-adherent
patient profiles.
We investigated whether data characterizing the centre,
patient and circumstances at the time predicted non-adher-
ence. Circumstances included: haemoglobin concentration;
intensive care unit (ICU) or ward care; normal versus out-
side normal working hours; weekdays versus weekends; the
months August to October (when anaesthetic and surgical
residencies start) versus other months. Patient characteristics
were: time between operation and randomization, age, sex,
EuroSCORE, operation type and pre-randomization transfu-
sions. Centres were characterized by recruitment rate: we
Table I. Multiple logistic regression models to identify predictors of non-adherence
Extra transfusions Withheld transfusions
OR (95% CI) P-value OR (95% CI) P-value
Adherence characteristics
Time from operation end (days) 097 (095, 098) <0001 103 (101, 104) <0001
Weekend versus weekday 078 (063, 095) 0013 179 (154, 209) <0001
ICU versus ward 468 (376, 583) 0001 307 (255, 369) <0001
Patient characteristics
Time between operation end
and randomization (days)
115 (107, 125) <0001
Age (years) 099 (097, 100) 0029
Cardiac procedure
CABG only Reference group <0001
CABG + Valve 136 (101, 183)
Valve only 175 (127, 240)
Other 104 (066, 165)
Transfused pre-randomization 149 (115, 193) 0003
Centre characteristics
Centre recruitment rate per month
≥6 patients/month Reference group <0001 Reference group 0022
4≤patients/month<6 104 (077, 139) 084 (061, 115)
3≤patients/month<4 223 (162, 305) 139 (099, 196)
<3 patients/month 154 (097, 244) 071 (041, 122)
Shaded boxes represent that the characteristic was not a significant predictor of that type of non-adherence, and therefore was not included in
the model.
CABG, coronary artery bypass graft, CI, confidence interval, ICU, intensive care unit, OR, odds ratio.
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hypothesized that higher recruitment would reduce non-
adherence.
Multivariate mixed-effects logistic regression models were
fitted. Participant-days in hospital were analysed, with each
day coded as adherent or not. Extra and withheld transfu-
sions were analysed separately. Explanatory variables were
modelled as fixed effects and included if significant
(P < 005), with patient identifier as a random effect. We did
not include highly correlated terms in the same model.
One or more instances of non-adherence occurred in
376% (753/2003) of patients (Murphy et al, 2015), 300%
and 452% in the restrictive and liberal groups, and at least
one instance was severe for 79%, 97% and 62% of patients
respectively. Approximately 80% of extra transfusions were
for clinical reasons, whereas most withheld transfusions
(67%) were oversights/errors. Non-adherence differed
between centres, although this was not strongly associated
with the average rate of recruitment (see Table S1 and Fig-
ure S2 for details).
The odds of extra transfusions (Table I) reduced with
increasing post-operative time, reduced at weekends,
increased with incidence of either pre-randomization transfu-
sions or valve procedures and increased at centres recruiting
less than 4 patients/month. Conversely, the odds of withheld
transfusions increased with increasing post-operative time,
increased at weekends, increased with increasing post-opera-
tive time before randomization and reduced with increasing
age.
Table II. Methods implemented to monitor, feedback and/or provide training on adherence
Methods Implemented by the Trial Management Team Across All Centres:
For centre research teams For clinical staff For clinical staff and centre research teams
Regular newsletters were sent to centres
to try to motivate staff
to improve adherence and maintain
interest in study.
Regular teaching slots about
the trial for new and existing
staff, the timing of which was
frequently aimed to coincide
with the start of residents’
rotations.
Colour-coded labels provided for
research and clinical staff to add
to patients’ notes and charts
(to clearly identify TITRe2 patients
and allocated group).
Mid-study centre visits included analysis
and discussion of
non-adherence with local research teams
to try to identify
centre-specific barriers to adherence
and potential solutions.
Nurses’ manuals at nursing
stations containing trial-specific
information and summaries
for treating the restrictive
and liberal groups according
to the trial protocol.
Daily haemoglobin transfusion checks
by research nurses to monitor
adherence with the protocol for
randomization and treatment according
to allocated group and to record
non-adherence. Checks were usually
done from Monday to Friday (due to
research nurse working patterns).
Checks provided useful additional
information if trial-related queries
arose and reinforced that the trial was
ongoing to staff on the cardiac units.
Reports were fed back to centres, both
at mid-study visits and
thereafter on a quarterly basis, describing
centre-specific
non-adherence over time and non-
adherence in relation to
other centres. An example is
shown in Figure S4.
A competition for clinical staff
to promote adherence was
attempted but this was difficult
to implement. However, informal
prizes were handed out at
meetings of study investigators
to commend centres that
achieved good adherence.
Trial-branded stationery produced to
remind clinical and research staff to
check and react to haemoglobin
concentrations.
Methods for avoiding non-adherence adopted by centres
with better adherence were shared at meetings of study
investigators. Research nurses were primary contributors
at these meetings.
Study posters in staff rooms.
Methods Implemented by Individual Centres:
Careful ‘handover’ between nursing shifts, highlighting the need to monitor the haemoglobin of a patient carefully and to randomize/transfuse
in the event of breaching the allocated threshold (Centre A).
Additional plastic wrist band/tag identifying that the patient was taking part in the trial; this band was alongside another band with the
participant’s ID details, which doctors and nurses had to check when prescribing/administering a red cell transfusion (Centre E).
Adding coloured covers to the patient’s paper medical records highlighting that the patient was taking part in research (Centre C).
Out of hours’/weekend reminder calls to ICU/ward (for participants known to be at risk of breaching their allocated threshold) to ask
whether a participant’s haemoglobin had been checked.
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Methods used to monitor adherence are described in
Table II. At several centres, research nursing methods were
amended to promote adherence: ensuring careful handover
between nursing shifts, providing additional wrist bands
identifying trial patients, adding coloured covers to paper
medical records and reminding colleagues to check haemo-
globin levels out-of-hours. Despite these initiatives, adher-
ence did not improve over the course of the study
(Figure S3).
These findings provide insights about the TITRe2 trial.
Despite investing in time-consuming data collection, non-
adherence was prevalent. However, severe non-adherence
occurred for only a small proportion of patients, consistent
with the assumptions made when calculating the target sam-
ple size (Pike et al, 2015), and good separation in average
haemoglobin was maintained between groups (Murphy et al,
2015).
The impact of non-adherence on the trial findings is
difficult to quantify. Centre-specific effect estimates for
the primary outcome did not vary by the frequency of sev-
ere non-adherence (Murphy et al, 2015). However, non-
adherence did not occur at random; patients who had extra
transfusions differed from those who had withheld transfu-
sions. A sensitivity analysis excluding non-adherent patients
was not performed because it would be biased. Nevertheless,
overall non-adherence must have attenuated the relative
treatment effect, i.e. biased the estimate towards unity.
We attempted to identify sources of non-adherence. With-
held transfusions most commonly occurred due to oversight
and might have reduced by more careful monitoring; extra
transfusions were more likely to be given sooner after surgery
for clinical reasons. Centres with higher recruitment rates
tended to be more adherent, consistent with greater familiar-
ity with trial procedures. A few centres were simply excellent,
typically because research staff innovated to promote adher-
ence or senior staff reported non-adherence as clinical inci-
dents.
Non-adherence persisted despite feedback and training.
We do not know whether some initiatives were successful
and adherence would have declined otherwise. We believe
that adherence did not improve because inadequate research
staffing was not addressed. This finding might cause future
researchers to question whether monitoring non-adherence
in such detail is warranted, especially given the intensity of
data collection required. Our answer is, unequivocally, yes.
Information about non-adherence is vital, e.g. to monitor its
frequency against assumptions when calculating the target
sample size. In terms of adherence to local transfusion guid-
ance, monitoring might be expected to improve adherence.
However, in TITRe2 everyone was acutely aware they were
being monitored, and adherence did not improve.
Non-adherence documented in TITRe2 is not directly
comparable to non-adherence reported in several previous
trials of different transfusion strategies (Johnson et al, 1992;
Bracey et al, 1999; Murphy et al, 2007; Hajjar et al, 2010).
Such studies reported only extra or withheld transfusions,
had different trial designs or defined non-adherence differ-
ently. Two more recent studies, which defined non-adherence
in a comparable way (Carson et al, 2011; Shehata et al,
2012), had broadly consistent rates.
We believe this is the first attempt to identify and classify
non-adherence to a transfusion strategy in this level of detail.
Non-adherence remains a key issue in trials comparing trans-
fusion strategies and our findings provide insight about when
and why they occur. Enhancing vigilance and providing
reminders appear to be the most successful ways to prevent
non-adherence, selecting centres with high projected recruit-
ment and established research infrastructure.
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